InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding InflaRx N.V. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 27 | 30 | +3 |
| Shares | 5.26M | 4.00M | −1.27M (−24.1%) |
| Value | $7.63M | $10.5M | +$2.91M (+38.1%) |
New holders (6)
Institutions that held InflaRx N.V. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 26,219 | $69.0K | 0.00% |
| Group One Trading, L.P. | 16,047 | $42.0K | 0.00% |
| Acadian Asset Management LLC | 9,499 | $25.0K | 0.00% |
| UBS Group AG | 5,361 | $14.0K | 0.00% |
| Axiom Investment Management LLC | 1,700 | $4.00K | 0.01% |
| JPMorgan Chase & Co | 121 | $0 | 0.00% |
Sold out (3)
Institutions that held InflaRx N.V. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| FNY Investment Advisers, LLC | 80,000 | $116.0K |
| Veritable, L.P. | 17,029 | $25.0K |
| BlackRock Inc. | 2,047 | $3.00K |